A novel ARMS-based assay for the quantification of EGFR mutations in patients with lung adenocarcinoma

Quantification of epidermal growth factor receptor (EGFR) mutations is important for the prediction of tyrosine kinase inhibitor (TKI) efficacy in patients with non-small cell lung cancer (NSCLC). However, clinicians lack a sensitive and convenient method to quantify EGFR mutant abundance. The prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yazhen, Guo, Zhiwei, Liu, Ying, Zheng, Xiyun, Yang, Guohua, Zheng, Guangjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778799/
https://www.ncbi.nlm.nih.gov/pubmed/29435017
http://dx.doi.org/10.3892/ol.2017.7679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778799/
https://www.ncbi.nlm.nih.gov/pubmed/29435017
http://dx.doi.org/10.3892/ol.2017.7679

Ejemplares similares